Methods useful in optimizing the treatment of neuropathies and targeting tissues with cosmetic botulinum injections

US11259740B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11259740-B2
Application numberUS-201815944528-A
CountryUS
Kind codeB2
Filing dateApr 3, 2018
Priority dateMay 3, 2011
Publication dateMar 1, 2022
Grant dateMar 1, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention pertains to methods of determining where, on the skin, a diagnostic, therapeutic, or cosmetic agent is likely to be most effectively applied (e.g., injected), and to methods for monitoring a patient after such an agent has been administered. The monitoring can produce information useful in determining whether a diagnostic, therapeutic (e.g., surgical), or cosmetic regime should be initiated, continued, continued in a modified fashion, or terminated (e.g., for a brief or prolonged period of time). The methods can be repeated periodically and use a non-invasive, in vivo form of digital image speckle correlation (DISC) to track deformation of the skin.

First claim

Opening claim text (preview).

We claim: 1. A method for identifying one or more injection sites for a cosmetic agent that induces muscle paralysis, the method comprising: (a) taking one or more photographs of a patient's skin in an area or areas to be treated with the cosmetic agent while the patient is at rest; (b) taking one or more photographs of the patient's skin in the area or areas to be treated with the cosmetic agent while the patient is performing an action; (c) performing digital image speckle correlation (DISC) analysis on the photographs from steps (a) and (b), thereby generating a vector diagram comprising a series of displacement vectors that each represents the movement of a pore from its at rest position to its final location; (d) identifying one or more locus of large stress in the vector diagram; and (e) identifying the location for the one or more injection sites for the cosmetic agent within the one or more locus of large stress. 2. The method of claim 1 , further comprising the step of injecting the cosmetic agent at the locus of large stress. 3. The method of claim 2 , wherein the steps (a) to (e) are subsequently repeated to monitor at least one effect on the skin after injection with the cosmetic agent. 4. The method of claim 3 , wherein the steps (a) to (e) are repeated within 24 weeks after injection with the cosmetic agent. 5. The method of claim 1 , wherein the one or more areas to be treated comprise skin of the face or neck. 6. The method of claim 1 , wherein the action performed by the patient comprises smiling; moving the jaw, lips or tongue; moving the eyes; or moving the forehead. 7. The method of claim 1 , wherein the one or more areas to be treated comprise skin having forehead lines, glabellar lines, or crow's feet. 8. A method for administering to a patient a cosmetic agent that induces muscle paralysis, the method comprising: (a) identifying one or more injection sites for the cosmetic agent comprising the steps of: (i) taking one or more photographs of the patient's skin in the area or areas to be treated with the cosmetic agent while the patient is at rest; (ii) taking one or more photographs of the patient's skin in the area or areas to be treated with the cosmetic agent while the patient is performing an action; (iii) performing digital image speckle correlation (DISC) analysis on the photographs from steps (a) and (b), thereby generating a vector diagram comprising a series of displacement vectors that each represents the movement of a pore from its at rest position to its final location; (iv) identifying one or more locus of large stress in the vector diagram; and (b) injecting the cosmetic agent into the one or more locus of large stress. 9. The method of claim 8 , wherein the one or more areas to be treated comprise skin of the face or neck. 10. The method of claim 8 , wherein the action performed by the patient comprises smiling; moving the jaw, lips or tongue; moving the eyes; or moving the forehead. 11. The method of claim 8 , wherein the one or more areas to be treated comprise skin having forehead lines, glabellar lines, or crow's feet. 12. The method of claim 8 , wherein the steps (a) to (e) are subsequently repeated to monitor at least one effect on the skin after injection with the cosmetic agent. 13. The method of claim 12 , wherein the steps (a) to (e) are repeated within 24 weeks after injection with the cosmetic agent.

Assignees

Inventors

Classifications

  • combined with drug delivery · CPC title

  • Measuring contraction of parts of the body, e.g. organ or muscle · CPC title

  • using image analysis (A61B5/1127 takes precedence) · CPC title

  • Evaluating nerves condition · CPC title

  • A61B5/442Primary

    Evaluating skin mechanical properties, e.g. elasticity, hardness, texture, wrinkle assessment · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11259740B2 cover?
The present invention pertains to methods of determining where, on the skin, a diagnostic, therapeutic, or cosmetic agent is likely to be most effectively applied (e.g., injected), and to methods for monitoring a patient after such an agent has been administered. The monitoring can produce information useful in determining whether a diagnostic, therapeutic (e.g., surgical), or cosmetic regime s…
Who is the assignee on this patent?
Univ New York State Res Found, The Research Foundation For State Univ Of New York
What technology area does this patent fall under?
Primary CPC classification A61B5/442. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).